- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 31, 2025 | 6.19M sh |
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $74K |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $0 |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $8.96M |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $20.14M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $1.92M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $1.71M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $30.39M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $54.01M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $38.1M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $54.32M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $78.83M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $104.62M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 6.01M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 5.98M sh |
| Capex restated | Q2 2025 · Mar 31, 2024 | $1.16M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $29.66M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $31.25M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $34.34M |
| Eps Diluted restated | Q2 2025 · Mar 31, 2024 | −$0.27 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.84 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | −$0.27 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.84 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $2.82M |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $5.92M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$1.59M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$5.01M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$1.33M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$4.98M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $1.49M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $949K |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $19.02M |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $35.04M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $20.52M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $35.99M |